THERMODYNAMIC CHARACTERIZATION OF DRUG-BINDING TO HUMAN SERUM-ALBUMIN BY ISOTHERMAL TITRATION MICROCALORIMETRY

被引:79
作者
AKI, H [1 ]
YAMAMOTO, M [1 ]
机构
[1] FUKUOKA UNIV,FAC PHARMACEUT SCI,DEPT PHARMACEUT,JONAN KU,FUKUOKA 81480,JAPAN
关键词
D O I
10.1002/jps.2600831213
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Binding sites on human serum albumin (HSA) for anionic drugs and fatty acids have been thermodynamically characterized by microcalorimetry. The binding and the thermodynamic parameters were directly computed from the calorimetric titration data at 37 degrees C in a phosphate buffer (pH 7.4) using one- and two-class binding models. From compensation analyses plotting the molar enthalpy change (Delta H-m,H-i) Versus those of the molar free energy (Delta G(m,i)) and and molar entropy (Delta S-m,S-i) for each class of binding sites, HSA binding sites were classified into groups S1, S2, and S3. Group S1 included high-affinity binding sites for site II-bound drugs, such as ibuprofen, flufenamic acid, and ethacrynic acid, and short- or medium-length alkyl-chain fatty acids; group S2 included low-affinity binding sites of site II-bound drugs and long-length alkyl-chain fatty acids; and group S3 contained the high-affinity binding sites for site I-bound drugs, such as phenylbutazone, oxphenbutazone, and warfarin, and long-length alkyl-chain fatty acids. High- and low-affinity bindings sites for salicylic acid and acetylaslicylic acid agreed with the regions of groups S3 and S2, respectively. Groups S1 and S2 were characterized by large negative values of Delta H-m,H-i and Delta S-m,S-i, reflecting van der Waals interaction and hydrogen-bonding formation in low dielectric media, and the main force to stabilize the binding complex in group S3 was a hydrophobic interaction, characterized by a small negative Delta H-m,H-i and minor or positive values of Delta S-m,S-i (entropy-driven).
引用
收藏
页码:1712 / 1716
页数:5
相关论文
共 41 条
[21]   DETECTION OF CARRIER HETEROGENEITY BY RATE OF LIGAND DIALYSIS - MEDIUM-CHAIN FATTY-ACID INTERACTION WITH HUMAN-SERUM ALBUMIN AND COMPETITION WITH CHLORIDE [J].
HONORE, B ;
BRODERSEN, R .
ANALYTICAL BIOCHEMISTRY, 1988, 171 (01) :55-66
[22]  
JANSSEN LHM, 1990, THERMOCHIM ACTA, V172, P192
[23]   PHYSICOCHEMICAL ASPECTS OF DRUG-PROTEIN INTERACTIONS - GENERAL PERSPECTIVE [J].
KLOTZ, IM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) :18-35
[24]  
KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
[25]   ENTHALPY-ENTROPY COMPENSATION .1. SOME FUNDAMENTAL STATISTICAL PROBLEMS ASSOCIATED WITH ANALYSIS OF VANT HOFF AND ARRHENIUS DATA [J].
KRUG, RR ;
HUNTER, WG ;
GRIEGER, RA .
JOURNAL OF PHYSICAL CHEMISTRY, 1976, 80 (21) :2335-2341
[26]   LAURATE BINDING TO HUMAN-SERUM ALBUMIN - MULTIPLE BINDING EQUILIBRIA INVESTIGATED BY A DIALYSIS EXCHANGE METHOD [J].
PEDERSEN, AO ;
HUST, B ;
ANDERSEN, S ;
NIELSEN, F ;
BRODERSEN, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 154 (03) :545-552
[27]  
PEDERSEN AO, 1988, J BIOL CHEM, V263, P10234
[28]   SERUM-ALBUMIN [J].
PETERS, T .
ADVANCES IN PROTEIN CHEMISTRY, 1985, 37 :161-245
[29]   THERMODYNAMICS OF PROTEIN ASSOCIATION REACTIONS - FORCES CONTRIBUTING TO STABILITY [J].
ROSS, PD ;
SUBRAMANIAN, S .
BIOCHEMISTRY, 1981, 20 (11) :3096-3102
[30]  
SJOHOLM I, 1979, MOL PHARMACOL, V16, P767